U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07133295) titled 'Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients' on May 16.
Brief Summary: Hypothyroidism is a prevalent endocrine disorder characterized by insufficient production of thyroid hormones. Traditional treatment involves daily administration of levothyroxine (L-T4), which can be challenging for some patients due to adherence issues. Recent studies have explored the efficacy of once-weekly L-T4 regimens, suggesting that they may provide a viable alternative for patients struggling with daily dosing The safety profile of once-weekly L-T4 has also been a focus of recent research. Evidence indicate...